| Cat.No. | Name | Information |
|---|---|---|
| M4748 | Pectolinarigenin | Pectolinarigenin is a dual inhibitor of COX-2/5-LOX with anti-inflammatory activity. |
| M19355 | Mannitol | DL-Mannitol is obtained by combining D-mannitol with a sample of Lmannitol obtained by reduction of L-mannono-1, Clactone. |
| M27790 | Kifunensine | Kifunensine, a potent and selective inhibitor of class I α-mannosidases isolated from Actinomycete, prevents α-mannosidases I from trimming mannose residues on glycoproteins. Kifunensine inhibits ERAD. |
| M4619 | Eupalinolide B | Eupalinolide B is a germacrane sesquiterpene isolated from Eupatorium lindleyanum. Eupalinolide B demonstrates potent cytotoxicity against A-549, BGC-823 and HL-60 tumour cell lines. |
| M4987 | Procyanidin B4 | A series of dimeric procyanidins (1-9) and some related polyphenols (10-15) were chosen as model compounds in a comparative investigation for various biological activities in order to obtain structure-activity relationships. |
| M18843 | Platycoside G1 | Platycoside G1 |
| M18842 | Eburicoic acid | Eburicoic acid |
| M18841 | Platycodigenin | Platycodigenin |
| M18840 | Eupalinolide H | Eupalinolide H |
| M18839 | Asiaticoside B | Asiaticoside B |
| M18838 | Oleonuezhenide | Oleonuezhenide |
| M18837 | Balanophorin A | Balanophorin A |
| M18836 | Glycoside St-J | Glycoside St-J |
| M18835 | Campneoside II | Campneoside II |
| M18834 | Malabaricone B | Malabaricone B |
| M18833 | (-)-Rengyolone | （-）-Rengyolone |
| M18832 | Zedoalactone B | Zedoalactone B |
| M18831 | Anhuienoside B | Anhuienoside B |
| M18829 | Protogracillin | Protogracillin |
| M18828 | Rupestonicacid | Rupestonicacid |
| M18827 | ZingibrosideR1 | ZingibrosideR1 |
| M18826 | Neoschaftoside | Neoschaftoside |
| M18825 | Theasaponin E2 | Theasaponin E2 |
| M18824 | Hypoglaunine D | Hypoglaunine D |
| M18823 | Wilfordinine D | Wilfordinine D |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
